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Alphaviruses are a large class of insect-borne human
pathogens and little is known about the host-factor
requirements for infection. To identify such factors,
we performed a genome-wide RNAi screen using
model Drosophila cells and validated 94 genes that
impacted infection of Sindbis virus (SINV), the proto-
typical alphavirus. We identified a conserved role for
SEC61A and valosin-containing protein (VCP) in facil-
itating SINV entry in insects and mammals. SEC61A
and VCP selectively regulate trafficking of the entry
receptor NRAMP2, and loss or pharmacological inhi-
bition of these proteins leads to altered NRAMP2
trafficking to lysosomal compartments and proteo-
lytic digestion within lysosomes. NRAMP2 is the
major iron transporter in cells, and loss of NRAMP2
attenuates intracellular iron transport. Thus, this
study reveals genes and pathways involved in both
infection and iron homeostasis that may serve as tar-
gets for antiviral therapeutics or for iron-imbalance
disorders.
INTRODUCTION
Alphaviruses are a large group of emerging and re-emerging
viruses that infect more than a million people annually, in part
due to a lack of vaccines or antiviral agents (Gould et al., 2010;
Strauss and Strauss, 1994; Weaver and Reisen, 2010). Many
alphaviruses cause a self-limiting disease characterized by
chronic illness, arthralgia, and myalgia, while others, such as
Venezuelan, Western, and Eastern equine encephalitis viruses
(VEEV, WEEV, and EEEV, respectively), cause fatal disease in
humans (Zacks and Paessler, 2010). Furthermore, VEEV,
WEEV, EEEV, and Chikungunya virus (CHIKV) are classified as
biodefense agents (Weaver and Reisen, 2010). As arthropod-Cell Reborne or arboviruses, most alphaviruses are dependent on a
mosquito vector and a vertebrate reservoir for their life cycle
(Strauss and Strauss, 1994; Weaver and Barrett, 2004).
Alphaviruses have a nonsegmented, single-stranded, posi-
tive-sense RNA genome with a 50 cap and 30 poly(A) tail (Strauss
and Strauss, 1994). The virus enters the cell by binding to a
plasma-membrane-associated receptor and trafficking via
clathrin-mediated endocytosis, where fusion in a low-pH com-
partment allows release of the viral genome into the cytoplasm
and the launch of cytoplasmic replication (Strauss and Strauss,
1994). We have a limited knowledge of the cellular factors
involved in the viral replication and pathogenesis of alpha-
viruses. Advances in genomic technologies and RNAi methodol-
ogies have allowed for the development of high-throughput,
genome-wide RNAi screens to identify cellular factors that
impact viral infection (Panda and Cherry, 2012). Robust in vitro
and in vivo RNAi technology coupled with complete genome
sequencing has made Drosophila an attractive model organism
for conducting genome-scale RNAi screens (Cherry, 2008;
Mohr and Perrimon, 2011). Importantly, a wide variety of viruses
can infect Drosophila cells, including a number of mammalian
arboviruses of medical and agricultural importance (Hughes
et al., 2012). RNAi screening in Drosophila systems has
advanced the discovery of host factors involved in various viral
infections, such as those due to influenza, dengue virus
(DENV), and Drosophila C virus (DCV) (Cherry et al., 2005; Hao
et al., 2008; Sessions et al., 2009).
To identify host genes that impact alphavirus infection, we
took advantage of the prototypical alphavirus, Sindbis virus
(SINV) (Strauss and Strauss, 1994). We performed a genome-
wide, high-throughput RNAi screen in Drosophila cells using
SINV and identified a large number of genes as factors involved
in SINV infection. Among the identified genes was dNRAMP, the
major cellular iron transporter. We previously demonstrated that
dNRAMP in insects and its ortholog, NRAMP2, in vertebrates are
entry receptors for SINV (Rose et al., 2011). Here, we report the
discovery of dSEC61A (Sec61a), Drosophila valosin-containing
protein (dVCP; TER94), and dPMSD11 (Rpn6) as required factorsports 5, 1737–1748, December 26, 2013 ª2013 The Authors 1737
for SINV infection at the level of entry. Moreover, we found that
dSEC61A, dVCP, and dPMSD11 positively regulate the expres-
sion level of the entry receptor protein dNRAMP. We extended
these studies and found that human SEC61A1 and VCP are
also required for SINV infection of mammalian cells. Depletion
of SEC61A and VCP led to altered intracellular trafficking of
NRAMP2 to lysosomes, leading to its degradation. Since
NRAMP2 is an essential iron transporter (Courville et al., 2006;
Hentze et al., 2004), depletion of SEC61A or VCP led to
decreased iron transport in human cells. Altogether, these re-
sults contribute to a deeper understanding of alphavirus biology,
the regulatory mechanisms that impact selective trafficking, and
iron homeostasis.
RESULTS
RNAi Screen in Drosophila Cells
Using a recombinant SINV (HRsp) that expresses GFP from a
subgenomic promoter (Burnham et al., 2007), we found that
SINV productively infectsDrosophila cells, consistent with previ-
ous work (Figure S1A; Hughes et al., 2012; Rose et al., 2011).
Thus, we optimized a high-content assay in a 384-well format
using dsRNAs against luciferase as a negative control and
dsRNA against virus-encoded GFP and the vacuolar ATPase
(vATPase) component vha26 (dATP6V1E, required for endoso-
mal acidification) as positive controls (Figures 1A and S1B).
We performed the genome-wide screen in duplicate and
identified 317 genes (2% of the Drosophila genome) whose
silencing impacted SINV infection with a robust Z score of >2
or <2 in duplicate (p < 0.001). The data set was enriched for
genes that have orthologs in both humans and mosquitoes
(p < 0.001), whereas Drosophila-specific genes were greatly
underrepresented (p < 0.001; Figure 1B). Of the 317 genes iden-
tified in the primary screen, 70 were overtly cytotoxic (robust
Z score < 2 in duplicate; 40% decrease in cell number).
Because cell death may influence data reliability, these genes
were not further pursued. For validation, we generated indepen-
dent dsRNAs against 227 genes. For large multiprotein com-
plexes, such as the proteasome, we chose to validate only a
subset of those genes. Of the 227 genes directly tested, we vali-
dated 94 genes (42%) that impact SINV infection (57 genes
(60%) promoted infection and 37 genes (40%) restricted infec-
tion; Figure 1C; Table S1). If we include additional members of
multiprotein complexes that were not directly tested, then we
validated 51 additional genes (65% of the total gene set; Table
S1). The SINV strain we used for our screen is a laboratory-
adapted strain derived from Sindbis AR339 (Sherman and
Griffin, 1990). Thus, we used a more virulent SINV strain,
dsTE12H, carrying a similar eGFP reporter (Rose et al., 2011),
and found that 75% of the genes that affected Sindbis HRsp
infection also impacted dsTE12H infection (Figure 1D).
We used a variety of functional annotation metrics to place
these validated genes into cellular pathways and subcellular
compartments that aremost likely relevant to SINV infection (Fig-
ure 1E). Genes involved in clathrin-mediated endocytosis and
vacuolar acidification were heavily represented, as required for
infection, and Gene Ontology (GO) enrichment analysis further
reinforced the finding that SINV entry factors were significantly1738 Cell Reports 5, 1737–1748, December 26, 2013 ª2013 The Autoverrepresented (Figure S1C). In contrast, biological processes
with a focus on transcription were highly enriched among the
restriction factors (Figure S1D). We further used Ingenuity
Pathway Analysis to determine whether the validated factors
that influence SINV infection relate to specific cellular gene net-
works. Several gene networks were enriched in our data set,
suggesting a functional role for these pathways in SINV infection
(Figure S1E).
In previous studies, investigators conducted genome-wide
RNAi screens to identify cellular factors that are required in the
life cycles of viruses such as DCV, influenza virus, and DENV
(Cherry et al., 2005; Hao et al., 2008; Sessions et al., 2009).
When we analyzed the data sets from these published screens
and compared them with the required factor data set obtained
by our screen, we observed minimal overlap at the gene level.
However, when we analyzed the overrepresented GO biological
processes, we found that SINV shared a number of biological
processes with DENV as well as with DCV (Figure S1F). Further-
more, we directly tested whether the validated genes required
for SINV infection were also required for the flavivirus West Nile
virus (WNV) and DCV. Out of the 57 genes required for SINV,
35 and 14 genes are also required for WNV and DCV infection,
respectively (Figure S1G). Interestingly, the COP I complex and
vATPase subunits are required for all three viruses examined,
suggesting that these complexes are coopted by disparate
viruses.
dSEC61A and the dVCP Complex Promote SINV
Infection
Our screen identified several cellular genes involved in the highly
conserved endoplasmic reticulum (ER)-associated protein deg-
radation (ERAD) pathway, dVCP, dUFD1L (Ufd1-like), dNPLOC4
(Npl4), and dSEC61A, and 22 components of the proteasome,
which also functions in ERAD, as required factors for SINV infec-
tion (Figure 1E). ERAD plays a central role in maintaining protein
quality control by preventing the toxic accumulation of misfolded
proteins inside the ER (Buchberger et al., 2010; Vembar and
Brodsky, 2008). So far, the role of these genes in SINV or any
alphavirus infection remains unknown; thus, we explored the
role of these factors in the SINV life cycle. We found that SINV
infection was attenuated when we depleted cells for each of
these genes using independent dsRNAs in two independent
cell lines (Figures 2A, 2B, and S2A). Treatment of DL1 cells
with these dsRNAs reduced the transcript or protein level of
each gene (Figures S2B and S2C) without any reduction in cell
viability (data not shown). A reduction in SINV protein expression
was also observed (Figure 2C). The requirement for these pro-
teins was specific for SINV, since their depletion did not impact
vesicular stomatitis virus (VSV) infection (Figure 2D). In a comple-
mentary approach, we assessed the impact of a pharmacolog-
ical inhibitor of VCP and SEC61A, Eeyarestatin1 (Eer1) (Cross
et al., 2009; Wang et al., 2008), on SINV infection in Drosophila
cells. Eer1 was shown to inhibit VCP function in Drosophila (Gri-
ciuc et al., 2010), and treatment of DL1 cells with Eer1 reduced
SINV infection, but not VSV infection, in a dose-dependent
manner (Figures 2E and S2D).
Protein quality control in the ER is monitored by the unfolded
protein response (UPR), which acts in concert with the ERADhors
Figure 1. Genome-wide RNAi Screen
(A) Schematic of the RNAi screen with robust Z scores plotted for each replicate.
(B) Fraction of candidates that have homologs in the indicated genera. Significant (p < 0.001) enrichment of conserved genes and underenrichment ofDrosophila-
specific genes (p < 0.001).
(C) Pie chart showing the number of genes identified as restriction or required factors.
(D) Overlap of factors regulating SINV infection using HRsp and dsTE12S strains of SINV. The number of genes in each category is in parentheses.
(E) Cellular map of SINV-host interactions. Validated genes were classified according to subcellular compartments and cellular processes using information from
GO, PANTHER, InterPro, and literature curation. Factors that facilitate (red) or restrict (green) infection are shown. Genes conserved in humans have an asterisk
and the ones in black are the additional components of a complex that were identified in the primary screen but not retested.
See also Figure S1.pathway tomaintain ER homeostasis (Travers et al., 2000;Walter
and Ron, 2011). Although we did not identify any genes involved
in the UPR in the genome-wide RNAi screen, we independently
tested five key UPR genes (IRE1, PERK, ATF6, XBP1, and
HSC70) in SINV replication and found that depletion of these fac-
tors did not impact SINV infection (Figure S2E). Furthermore,
upon SINV infection in Drosophila cells, we did not observe
increased splicing of XBP1, a hallmark of UPR (data not shown).
Altogether, these data suggest that SEC61A and the VCP-Cell ReUFD1L-NPLOC4 complex play a specific role in SINV virus infec-
tion, and that this is not likely due to a global disturbance of ER
quality control.
dSEC61A and the dVCP Complex Are Required for SINV
Infection in Adult Flies
We next exploited the powerful genetic tools available in
Drosophila to determine whether these ERAD-associated pro-
teins promote infection at the organismal level. dVCP, dUFD1L,ports 5, 1737–1748, December 26, 2013 ª2013 The Authors 1739
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Figure 2. The SEC61A and VCP Complex Promotes SINV Infection
(A–D) Drosophila cells were pretreated with the indicated dsRNA and infected by the indicated virus.
(A) Representative images showing SINV infection after the indicated dsRNA treatment.
(B) Normalized percent SINV infection from (A). Mean ± SD from four independent experiments is shown; *p < 0.05.
(C) Virally expressed GFP was examined by immunoblot and compared with the control tubulin. A representative blot is shown.
(D) Normalized percent VSV infection after the indicated dsRNA treatment. Mean ± SD from four independent experiments is shown; *p < 0.05.
(E) Drosophila cells were treated with the indicated concentrations of Eer1 1 hr before infection and then infected with SINV for 18 hr. GFP and tubulin expression
was examined by immunoblot. A representative blot is shown.
(F) Adult flies expressing dsRNA against the indicated ERAD-associated components or control flies were infected with SINV and virus production wasmonitored
at day 3 postinfection by plaque assay on BHK21 cells. Mean ± SD from three independent experiments is shown; *p < 0.05.
(G) Aag2 cells were treated with dsRNA against A. aegypti SEC61A or control and infected with SINV. Mean ± SD from three independent experiment is
shown; *p < 0.05.
(H) Aag2 cells were treated with the indicated concentrations of Eer1 1 hr before infection and then infected with SINV for 16 hr. GFP and tubulin expression was
examined by immunoblot. A representative blot is shown.
See also Figure S2.dNPLOC4, and dSEC61A are essential genes (Leo´n and
McKearin, 1999; Wang and Ward, 2010). Therefore, we used
heat-shock-inducible in vivo RNAi to deplete these proteins in
adult flies, and found that depletion of each component of the
VCP-UFD1L-NPLOC4 complex as well as SEC61A significantly
attenuated SINV infection (Figure 2F).
SEC61A and VCP Promote SINV Infection of Mosquito
Cells
Since the natural vector for SINV is a mosquito (Weaver and Bar-
rett, 2004), we investigated the role of SEC61A and VCP during
SINV infection of mosquito cells. We generated dsRNA against
the annotated Aedes aegypti SEC61A ortholog (AAEL010716)
and found that depletion of this gene resulted in amodest reduc-
tion in SINV virus production (Figure 2G). This may be due to
redundancies, since many organisms have multiple SEC61A
orthologs and the Aedes aegypti genome is an incompletely an-
notated draft sequence. We were unable to identify clear ortho-
logs of VCP, UFD1L, or NPLOC4 in A. aegypti. Therefore, to
examine the role of VCP, we used two small-molecule1740 Cell Reports 5, 1737–1748, December 26, 2013 ª2013 The Autinhibitors: Eer1 and DBeQ (Chou et al., 2011). We found that
treatment with either Eer1 or DBeQ substantially reduced SINV
infection in mosquito cells (Figures 2H and S2F).
SINV Entry Is Regulated by SEC61A and VCP
We next characterized the mechanism by which these proteins
promote SINV infection. Since we observed a reduction in
SINV protein expression upon the depletion of these compo-
nents (Figure 2C), we reasoned that they likely affect SINV at
an early stage of infection. We first determined whether
SEC61A, VCP, UFD1L, or NPLOC4 regulates a pre- or postentry
step of SINV infection. To this end, we performed an ‘‘acid
bypass’’ assay, which exploits the fusion of bound viruses with
the plasma membrane when the extracellular pH is decreased
to that of an endosomal compartment, thereby bypassing endo-
somal entry requirements (Liao and Kielian, 2005). First, we
validated this assay by depleting the vATPase component
dATP6V1E, which is required for endosomal entry but should
be dispensable for entry from the plasma membrane. Indeed,
low-pH treatment of plasma-membrane-bound SINV bypassedhors
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Figure 3. SEC61 and VCP Are Required for SINV Entry
(A) Drosophila cells pretreated with the indicated dsRNAs were infected with
SINV-GFP and subsequently treated with PBS pH 7.2 or pH 5.5. Relative
percent infection for each treatment is shown normalized to control dsRNA.
Data represent mean ± SE from five independent experiments; *p < 0.05.
(B) Drosophila cells were treated with Eer1 at the indicated time pre- or
postinfection by SINV-GFP (upper panel) or VSV-GFP (lower panel) and
infection was monitored by immunoblot. A representative blot is shown.
(C) Drosophila cells stably expressing HA-dNRAMP were treated with the
indicated dsRNA, and NRAMP levels were examined by immunoblot against
HA compared with actin control. A representative blot is shown.
(D) Endogenous dNRAMPmRNAwas examined byRT-PCR after the indicated
dsRNA treatment. The relative level of dNRAMP was normalized to control
RP49. Mean ± SD from three independent experiments is shown; *p < 0.05.
See also Figure S3.vATPase dependence and enhanced SINV infection as ex-
pected, whereas dsRNA treatment against the viral reporter
GFP could not be bypassed (Figure 3A). Under these conditions,
we observed that the low-pH treatment bypassed the require-
ment for dSEC61A similarly to what was observed for dATP6V1E
(Figure 3A). Furthermore, we were able to bypass the require-
ments for VCP, UFD1L, and NPLOC4, although the rescue was
more modest (Figure 3A).
To further explore themechanistic requirement forSEC61Aand
VCP during SINV infection, we took advantage of a time-of-addi-
tion assay. First, we used ammonium chloride (NH4Cl), which
blocks endosomal acidification and SINV entry, to identify the
time after which the virus entered the cells and was thus insensi-
tive to treatment. Pretreatment of cells with NH4Cl attenuated
SINV infection, but SINV infection became resistant to NH4Cl at
2 hr postinfection (Figures S3A and S3B), suggesting that SINV
had completed entry by 2 hr postinfection. Pretreatment of cells
with the VCP inhibitor Eer1 reduced SINV infection, whereasCell ReEer1 treatment at 2 hr postinfection did not restrict SINV infection
(Figure 3B). In contrast, VSV infection was unaffected by Eer1
treatment at all time points (Figure 3B). Altogether, these data
demonstrate thatdSEC61AanddVCPplaya role in theearly stage
(likely during or immediately after virus entry) of SINV infection.
NRAMP Expression Is Altered by Loss of SEC61A
and VCP
Because both SINV and VSV entry are dependent on clathrin-
mediated endocytosis and acidification, and dSEC61A and
dVCP specifically promote SINV entry, these data suggested
that these genes promote a distinct aspect of SINV infection.
Since SINV, but not VSV, uses NRAMP as a receptor (Rose
et al., 2011), we examined whether the SINV-specific require-
ment for these proteins reflected changes in the level of NRAMP.
Because antibodies to endogenous dNRAMP are unavailable,
we generated a cell line stably expressing epitope-tagged
dNRAMP (Figure S3C). We validated that dNRAMP mRNA and
protein levels are significantly reduced by dsRNA treatment
against dNRAMP (Figures 3C and 3D). RNAi against dSEC61A
and dVCP reduced dNRAMP levels, whereas neither impacted
mRNA levels (Figures 3C and 3D). This effect is not likely due to
a general requirement for these proteins in plasma-membrane-
receptor expression, as the levels of the plasma membrane re-
ceptor dToll7 or Drosophila E-cadherin (DE-cadherin) were not
decreased by RNAi against this panel of genes (Figures S3D
and S3E). Consistent with the observed decrease in NRAMP
levels, SINV binding to the plasma membrane was significantly
decreased when we knocked down dSEC61A, and modestly
decreased with VCP knockdown (Figure S3F). Taken together,
these data suggest that dSEC61A and dVCP play a role in SINV
infection, likely by positively regulating expression of dNRAMP.
The Proteasome Promotes SINV Entry
Protein substrates of ERAD are targeted to the proteasome for
subsequent degradation (Vembar and Brodsky, 2008). Our
screen identified 22 proteasomal components as required for
SINV infection (Figure S1C). We focused on dPSMD11, which is
a non-ATPase subunit of the 19S regulator complex of the 26S
proteasome and whose depletion does not significantly impact
cell viability (data not shown). Knockdown of dPSMD11 (Fig-
ureS2B) significantly reducedSINV infection (Figure 4A),whereas
VSV infectionwasnot affected (Figure4B), further suggesting that
the proteasomeplays a crucial and specific role in SINV infection.
Like dSEC61A and dVCP, dPSMD11 functions during SINV
entry, since low-pH treatment substantially bypassed the require-
ment of dPSMD11 in SINV infection (Figure 4C) and dPSMD11
depletion led to a substantial decrease in dNRAMP protein levels
(Figure 4D). Altogether, these data suggest that the proteasome
regulates SINV entry, likely by promoting dNRAMP expression.
However, the incomplete rescue of SINV infection by low-pH
treatment suggests that the proteasome might function in addi-
tional downstream steps in the SINV life cycle.
SEC61A1 and VCP Promote SINV Infection of Human
Cells
Since the SINV entry pathway is highly conserved and verte-
brates are a natural host, we next examined the role of theseports 5, 1737–1748, December 26, 2013 ª2013 The Authors 1741
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Figure 4. The Proteasomal Component dPSMD11
Regulates SINV Entry
(A and B) Drosophila cells depleted of dPSMD11 were
infected with (A) SINV or (B) VSV. The normalized fold
change in infection from three independent experiments
is presented as mean ± SD; *p < 0.05.
(C) Drosophila cells pretreated with dPSMD11 or control
dsRNA were infected with SINV-GFP and subsequently
treated with PBS pH 7.2 or pH 5.5. Relative percent
infection is shown. Data represent mean ± SE from three
independent experiments; *p < 0.05.
(D) Drosophila cells expressing HA-dNRAMP were
treated with the indicated dsRNA and the level of
dNRAMP was examined by immunoblot against HA and
compared with the actin control. A representative blot is
shown.components in SINV infection of mammalian cells, and found
that siRNAs to VCP and SEC61A1 induced a 2- to 3-fold reduc-
tion in SINV infection in human osteosarcoma (U2OS) cells (Fig-
ures 5A–5C), whereas VSV infectionwas not reduced (Figure 5D).
We verified the decrease in SINV infection using two indepen-
dent siRNAs for each gene individually or together, which
depleted SEC61A1 or VCP protein levels by more than 70% as
measured by immunoblot (Figures S4A and S4B). Moreover, pre-
treatment of U2OS cells with the VCP inhibitor Eer1 (Figure 5E) or
DBeQ (Figures 5F and S4C), or the proteasome inhibitor MG132
or lactacystin (Figure 5G) attenuated SINV infection in a dose-
dependent manner in the absence of cytotoxicity. Because
sentinel cells, such as macrophages, are among the first cells
to be infected during infection of the mammalian host and are
required for efficient spread (Klimstra et al., 2003), we used a
humanmonocytic cell line and found that treatment of THP1 cells
with the VCP inhibitor Eer1 or DBeQ significantly decreased
infection (Figure S4D).
To define the step in the viral life cycle that is restricted by
these drugs in human cells, we performed time-of-addition
studies. SINV entry in U2OS cells occurred within 2 hr of infec-
tion, since viral protein expression was no longer sensitive to
NH4Cl by 2 hr postinfection (Figure S4E). Whereas pretreatment
of U2OS cells with either Eer1 or MG132 attenuated infection,
infection was largely insensitive to treatment at 2 hr postinfection
(Figures S4F and S4G). This indicates that VCP and the protea-
some are required during or soon after virus entry in mammalian
cells. Also, depletion of SEC61A or VCP led to a reduction in
the level of NRAMP2 protein (Figure 5H). These results suggest
that SEC61A and VCP impact SINV entry, likely by regulating
NRAMP2 expression across hosts.
SEC61A and VCP Regulate NRAMP2 Localization
Previous studies have shown that NRAMP2 rapidly shuttles
between endosomal compartments and the plasma membrane
(Lam-Yuk-Tseung andGros, 2006; Tabuchi et al., 2002). Further-
more, VCP regulates the endosomal dynamics and endosomal
transport of transferrin receptor (TFR) and caveolin 1 (Ramana-
than and Ye, 2012; Ritz et al., 2011). Since TFR traffics via a
similar route as NRAMP2, we tested whether VCP or SEC61A
impact the dynamics of NRAMP2. In control cells, NRAMP2
was largely present in early endosomes, as measured by coloc-1742 Cell Reports 5, 1737–1748, December 26, 2013 ª2013 The Autalization with early endosomal antigen 1 (EEA1) (Figure 6A), and
overlapped poorly with the late endosome and lysosome marker
LAMP1 (Figure 6B; quantified in Figure S5A). Depletion of
SEC61A and VCP resulted in enlargement and perinuclear clus-
tering of EEA1-positive endosomes (Figure 6A), as previously re-
ported for VCP depletion (Ramanathan and Ye, 2012; Ritz et al.,
2011), although EEA1 levels were not affected (Figure 6E). Impor-
tantly, overlap of NRAMP2 with EEA1 decreased, and overlap
with LAMP1 increased in both SEC61A- and VCP-depleted cells
(Figures 6A, 6B, and S5A). Similarly, treatment of U2OS cells
with Eer1 or DBeQ resulted in decreased localization of NRAMP2
to EEA1-positive early endosomes (Figure S5C) and increased
colocalization of NRAMP2 with LAMP1-positive vesicles (Fig-
ure S5D). These data suggest that NRAMP2 is mistargeted
to late endosomes and lysosomes upon depletion of SEC61A
and VCP. We next examined whether lysosomal proteases are
responsible for the loss of NRAMP2 protein, and found that treat-
ment of cells with lysosomal protease inhibitors (Reusch et al.,
1999) significantly restored NRAMP2 expression as measured
by immunoblotting (Figures 6C and 6D) and increased the
degree of colocalization of NRAMP2 with LAMP1 (Figures S5A
and S5B).
To determine whether SEC61A and VCP impact endosomal
trafficking globally, we assessed the effect of SEC61A and
VCP depletion on infection by other viruses that, like SINV,
require clathrin-mediated endocytosis for entry. In addition to
VSV (Figure 5D), infection of U2OS cells by two alphaviruses,
CHIKV andRossRiver virus (RRV), whose entry is clathrin depen-
dent but NRAMP2 independent (Rose et al., 2011; Sharkey et al.,
2001; Sourisseau et al., 2007; P.P.R., D.P., and S.C., unpub-
lished data), was not impaired by depletion of SEC61A or VCP
(Figures S5E and S5F). These data suggest that SEC61A and
VCP may not globally impact endocytosis or virus infection.
A recent paper demonstrated that TFR recycling is delayed by
VCP depletion, but whether this delay has functional conse-
quences is unknown (Ramanathan and Ye, 2012). Because
both NRAMP2 and TFR expression are regulated by the level of
iron, andbothproteins trafficvia similar routes,we testedwhether
TFR localization, degradation, or function is also regulated by
SEC61A and VCP.We found that the level of TFR protein was un-
affected by depletion of SEC61A or VCP (Figure 6E). We then
examined whether SEC61A and VCP impacted entry of Juninhors
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Figure 5. SEC61A and VCP Regulate SINV Infection in Human Cells
(A and B) U2OS cells were transfectedwith the indicated siRNAs. At 96 hr posttransfection, cells were infectedwith SINV (moi = 1). Cells were fixed and processed
at 8 hpi. A representative image is shown in (A) and quantification from three independent experiments is shown in (B); *p < 0.05.
(C) The experiment was performed as in (A), but cells were processed for immunoblot analysis for GFP and actin. A representative blot is shown.
(D) The experiment was performed as in (A), but cells were infected with VSV (moi = 2) for 8 hr. Quantification from three independent experiments is shown.
(E–G) U2OS cells were pretreated with the indicated drugs and then infected with SINV (moi = 1) for 7 hr. GFP and actin expression was examined by immunoblot.
A representative blot is shown.
(H) U2OS cells were transfected with the indicated siRNAs. After 48 hr, the cells were transfected with HA-NRAMP2 and processed for immunoblot at 30 hr for
NRAMP2 and actin. A representative blot is shown.
See also Figure S4.virus, a virus that uses TFR as an entry receptor (Radoshitzky
et al., 2007), using Junin virus glycoproteins pseudotyped on a
VSV core. We found that infection of the pseudotyped virus was
not affected by depletion of SEC61A or VCP (Figure S5G). These
data suggest that the role of SEC61A and VCP in NRAMP2 traf-
ficking is distinct from the previously described role of VCP in
regulating the kinetics of TFR recycling. Rather, SEC61A and
VCPmight selectively regulate the lysosomal deliveryof particular
transmembrane cargo proteins. To test this, we screened a panel
ofmembrane proteins in human cells depleted of SEC61Aor VCP
for changes in protein levels (Figures 6E–6H). In addition to TFR,
we tested for effects onpolio virus receptor (PVR), cadherin, junc-
tional adhesion molecule 1 (JAM1), and b1 integrin, which are all
plasma-membrane-associated proteins with single-transmem-
brane domains. Because NRAMP2 is a multipass transmem-
brane protein (12 transmembrane domains), we also tested for
effects on three ion transporters, ATP1A1, ATP7A, and GLUT1,
which have eight or more transmembrane domains. We found
that the expression of TFR, EEA1, cadherin, JAM1, PVR,
ATP7A, and ATP1A1 were not affected by the loss of SEC61A
orVCP. In contrast,we found that in addition toNRAMP2, expres-
sion of b1 integrin and GLUT1 also requires SEC61A and VCP.
SEC61A, VCP, and the Proteasome Promote NRAMP-
Dependent Iron Transport
NRAMP is themajor cellular iron transporter and its expression is
tightly regulated to ensure proper iron uptake, since either too
much or too little iron can result in pathology (Hentze et al.,
2004) andNRAMP levels largely dictate intracellular iron concen-Cell Retrations (Andrews and Schmidt, 2007).Therefore, we tested
whether these factors also promote iron transport. First, we
explored this in Drosophila cells by adapting a well-established
calcein-acetoxymethyl (calcein-AM)-based fluorescence assay
to monitor iron uptake (Cabantchik et al., 1996). Treatment of
Drosophila cells with iron led to a reduction in fluorescence
(Figure 7A). This reduction was dependent on dNRAMP, since
depletion of dNRAMP significantly attenuated iron-induced
changes in fluorescence (Figure 7A). Similarly, depletion of
dSEC61A or dPSMD11 also prevented quenching of fluores-
cence, suggesting a reduction in iron transport (Figures 7A and
7B). These data suggest that optimal dNRAMP-dependent iron
import requires SEC61A and the proteasome. We extended
these studies to human cells and examined whether SEC61A
and VCP affected NRAMP2 activity by assaying for iron transport
in human embryonic kidney 293T (HEK293T) cells that ectopi-
cally express Nramp2 (Wetli et al., 2006). Consistent with the
results obtained in Drosophila cells, we found that depletion of
either SEC61A or VCP led to decreased iron uptake (Figure 7C).
DISCUSSION
Over the past several decades, studies in Drosophila have been
central to our understanding of various fundamental biological
processes. In addition to being a public health threat, alphavi-
ruses are gaining popularity as potential antitumor agents as
well as a vaccine platform (Atkins et al., 2008; Quetglas et al.,
2010; Riezebos-Brilman et al., 2006). To expand our knowledge
of alphavirus-host interactions, we performed a genome-wideports 5, 1737–1748, December 26, 2013 ª2013 The Authors 1743
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Figure 7. SEC61A and VCP Regulate Iron
Transport
(A and B) Drosophila cells expressing dNRAMP
were treated with the indicated dsRNA. After
72 hr (A) or 48 hr (B), cells were treated with cal-
cein-AM for 1 hr and subsequently treated with
vehicle (no iron) or 20 mM iron (iron). Relative
fluorescence intensity is shown. Data represent
mean ± SE from three independent experiments;
*p < 0.05.
(C) HEK293T cells expressing mouse Nramp2
were transfected with the indicated siRNAs. After
72 hr, iron transport was examined by calcein-AM
assay. Mean ± SE of the relative fluorescence
intensity for five independent experiments is
shown; *p < 0.05.RNAi screen in Drosophila as a model insect. Importantly, we
identified several factors and cellular pathways that either pro-
mote or restrict SINV infection. Additional plasma-membrane-
associated genes, such as dSLC22A13 (orct2) and dSCARB1
(peste), promote infection, raising the possibility that these
factors act as coreceptors. A large number of genes that we
validated have human orthologs, suggesting that many of
these genes may play similar roles in regulating SINV infection
in mammalian systems. Thus, further exploration of these
genes will undoubtedly reveal new insights into alphavirus-host
interactions.
In this report, we focused on a group of genes that are associ-
ated with ERAD, which included all three subunits of the VCP-
UFD1L-NPLOC4 complex, SEC61A, and 22 subunits of the
proteasome. Interestingly, although the proteasome impacts
the replication of many viruses, including positive-strand RNA
viruses such as flaviviruses (Gao and Luo, 2006; Gilfoy et al.,
2009), to our knowledge, a role for the proteasome in alphavirus
entry has not been previously described. We found that deple-
tion of dSEC61A, dVCP, and dPMSD11 reduced the levels of
the entry receptor dNRAMP posttranscriptionally. The expres-
sion of Toll-7 and DE-cadherin, two plasma-membrane-associ-
ated proteins (Nakamoto et al., 2012; Tepass, 1999), was not
altered by depletion of SEC61A and VCP, suggesting that these
genes may not regulate membrane proteins globally. Our find-
ings for dNPLOC and dUFD1L demonstrate that these genes
are also important, albeit more modestly, for SINV entry. This
may be due to technical reasons, such as differences in the effi-
ciency of silencing, or to the fact that the different assays
employed have differential sensitivity. Alternatively, it is possible
that these genes work through a different mode of action.
One possible explanation for the control of NRAMP by these
genes is that the ERAD-proteasome pathway targets a negative
regulator of NRAMP stability for degradation. However, if the
proteasome degraded NRAMP downstream of ERAD, loss of
proteasomal components would lead to increased NRAMP
levels. Furthermore, we could not rescue in NRAMP degradationNRAMP2 and actin are shown for a representative experiment, and quantifica
shown; *p < 0.05.
(E–H) U2OS cells were treated with the indicated siRNAs for 72 hr and the levels
shown.
See also Figure S5.
Cell Reupon simultaneous depletion of SEC61A or VCP with several
known negative regulators of NRAMP in Drosophila cells, such
as NDFIP and WWP2 (data not shown) (Foot et al., 2008). This
raised the possibility that SEC61A and VCP target a yet-
unknown negative regulator of NRAMP2 or, more likely, act in
an ERAD-independent manner. A recent study found that VCP
regulates early endosomal morphology and the kinetics of
transferrin trafficking (Ramanathan and Ye, 2012), and NRAMP2
can be mislocalized to lysosomes under some conditions (Lam-
Yuk-Tseung and Gros, 2006). We found that SEC61A and VCP
are required for the proper endosomal trafficking of NRAMP2.
Thus, our data support an ERAD-independent role for these
genes.
To explore the specificity of this SEC61A- and VCP-depen-
dent trafficking, we first demonstrated that general endocytosis
and the expression of a number of plasma-membrane and endo-
somal proteins are unaffected. Rather, specific cargoes (mem-
brane receptors) are subject to regulation by SEC61A and
VCP. In addition to NRAMP2, expression of GLUT1 and b1 integ-
rin also requires SEC61A and VCP activity. This specificity
cannot be simply explained by structural similarities. First,
NRAMP2 is a multipass transmembrane protein and b1 integrin
is not. Second, GLUT1, but not other multipass proteins tested,
was impacted by loss of SEC61A or VCP function. We consid-
ered whether SEC61A and VCP might regulate the activity of
sorting nexins, which are known to retrieve selective cargo
from lysosomal transport and degradation. However, whereas
GLUT1 and ATP7A are cargoes for sorting nexin 27 (SNX27),
b1 integrin is a cargo for sorting nexin 17 (SNX17) (Steinberg
et al., 2012, 2013), indicating that the cargo dependencies we
identified are distinct from those identified for known sorting
nexins. The cytoplasmic domain of NRAMP2 isoform 1 has an
‘‘LL’’ motif, which is required for clathrin-mediated endocytosis
and targeting to endosomes and lysosomes (Lam-Yuk-Tseung
et al., 2005). However, such classic LL motifs are absent from
GLUT1 and b1 integrin, both of which are internalized by cla-
thrin-independent endocytosis (Maldonado-Ba´ez et al., 2013),tion of NRAMP2 levels (mean ± SE) from four independent experiments is
of indicated proteins were analyzed by immunoblot. Representative blots are
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indicating that SEC61A1 and VCP regulate cargoes that are
internalized by different mechanisms. This suggests that VCP
and SEC61A1might target these cargos not at the plasmamem-
brane, but rather at a downstream compartment such as the
sorting endosome. Furthermore, VCP inhibition or depletion
impacts different cargoes differently. Although it slowed TFR re-
cycling, it did not target it for degradation (Ramanathan and Ye,
2012; our data), and Caveolin-1 was blocked from degradation,
whereas NRAMP2 was degraded (Ritz et al., 2011; our results).
Altogether, our results indicate that only a subset of plasma
membrane cargoes are specifically regulated by SEC61A and
VCP, pointing toward a yet uncharacterized role in endosomal
sorting.
NRAMP is the major iron transporter in cells, and it is known to
be tightly regulated posttranscriptionally and posttranslationally
to control intracellular iron concentrations (Brasse-Lagnel et al.,
2011; Foot et al., 2008). We found that SEC61A and VCP
promote iron import across hosts by regulating NRAMP expres-
sion via a mechanism that has not been previously described.
This has important implications for pathologies associated with
iron homeostasis dysfunction. The other two plasma-membrane
proteins we found to be dependent on SEC61A and VCP are
GLUT1 and b1 integrin. GLUT1 is a glucose transporter that
plays essential roles in energy metabolism, and b1 integrin
impacts diverse biological processes, including cell adhesion,
suggesting a role for SEC61A and VCP in the regulation of
cellular homeostasis more broadly. Further study will clarify
this regulatory pathway and perhaps elucidate new therapeutic
targets for treating alphaviruses or human disorders associated
with an iron imbalance, as well as provide insight into the regula-
tion of energy metabolism.
EXPERIMENTAL PROCEDURES
Cells, Viruses, and Reagents
Insect cells were maintained as previously described (Rose et al., 2011). Drugs
were purchased from Sigma. SINV (HRsp-GFP and dsTE12H-GFP) stocks
were propagated in C6/36 cells (Burnham et al., 2007). VSV-GFP was propa-
gated in baby hamster kidney 21 (BHK-21) cells (Ramsburg et al., 2005). Viral
titers for multiplicity of infection (moi) calculations were determined in BHK-21
cells. The following antibodies were used in this study: anti-SEC61A1
(ab15575; Abcam), anti-VCP (ab11433; Abcam), anti-Actin (Sc 47778; Santa
Cruz Biotechnology), anti-GFP (Sc-9996; Santa Cruz Biotechnology), anti-
DE-cadherin (Developmental Studies Hybridoma Bank), anti-LAMP1 (H4A3;
Developmental Studies Hybridoma Bank), anti-tubulin (T5168; Sigma), anti-
EEA1 (610457; BD Transduction Laboratories), anti-hemagglutinin (anti-HA,
clone 3F10; Roche), anti-ATP1A1 (Roche), anti-cadherin (Sc 1499; Santa
Cruz Biotechnology), anti-PVR (Sc 27754; Santa Cruz Biotechnology), anti-
JAM-1 (36-1700; Invitrogen), anti-ATP7A (Setty et al., 2008), anti-GLUT1
(a generous gift from M. Birnbaum), and anti-b1 integrin (610467; BD Trans-
duction Laboratories).
Drosophila Genome-wide RNAi Screen
DL1 cells (18,000/well) were seeded into 384-well plates prearrayed with
250 ng/well dsRNA (Ambion) in 10 ml of serum-free media using automated
liquid handling (Wellmate; Thermo Scientific). One hour later, 20 ml of complete
media was added, and the plates were incubated for 3 days and then infected
with SINV (moi = 10) for 36 hr. The plates were fixed in 4% formaldehyde in
PBS for 10 min and washed twice in PBS. Cells were stained with 5 mg/mL
Hoechst 33432 and washed twice with PBS. GFP and DAPI images were
captured, and three sites per well were imaged at 203 (ImageXpress Micro;
Molecular Devices). Automated image analysis (MetaXpress; Molecular1746 Cell Reports 5, 1737–1748, December 26, 2013 ª2013 The AutDevices) was used to segment the images and determine the number of
DAPI-positive and GFP-positive cells. The percentage of infected cells was
calculated, averaged for the three sites, and log transformed. The platemedian
and interquartile range was calculated. These metrics were used to calculate a
robust Z score for each well using the following equation: [(log10(%infection)
log10(median)/(IQR 3 0.74)] (Zhang et al., 2006). Candidates were identified
as positive if the robust Z score was <2 or >2 in both independent replicates
(p < 0.001). Cytotoxic candidates were identified based on nuclei counts and
those with a robust Z score < 2 in duplicate wells were considered toxic
(40% decrease in cell number).
Secondary Screen and Statistical Analysis
Independent secondary amplicons were chosen from a different region within
the target gene using SNAPdragon (http://flybase.org) and used to generate
dsRNA against candidate genes. A validation screening assay was performed
as in the primary screen for SINV HRsp using either SINV HRsp or dsTE12H.
Candidates were identified as positive if the robust Z score was <1.5
or >1.5 in duplicate (p < 0.009).
Viral Infection of Insect Cells
DL1 cells in 96- or 384-well plates were infected with SINV at an moi of 20 for
42 hr. In 12-well plates, DL1 cells were infected with SINV at an moi of 5 for
18–20 hr. DL1 cells were infected with VSV at an moi of 5. Aag2 cells were in-
fected with SINV at an moi of 3 for 16 hr.
Adult Fly Infections
Flies obtained from the Bloomington Stock Center or VDRC (TER94: v24354;
CG4673: v21917; Ufd1-like: v24700; Sec61alpha: v42763) were crossed to
hs-GAL4 and the adult progeny (4–7 days old) were heat shocked at 37C
every other day to induce RNAi throughout the experiment. Infections were
carried out as described previously (Cherry and Perrimon, 2004) using the
indicated genotypes. Virus production was assayed by crushing five flies
and titering on BHK cells in three independent experiments (Rose et al., 2011).
Human Cells
Human cells were transfected with a pool of two independent siRNAs for VCP
(s14765, Ambion; and J008727-11, Dharmacon) and SEC61A1 (s26721 and
s26722; Ambion) using Hiperfect (QIAGEN) at 20 nM according to the manu-
facturer’s instructions. At 72 hr posttransfection, cells were replated in a
96-well format (30,000 cells per well) for infection or iron transport assays,
or replated in 12-well plates (300,000 cells per well) for virus infection.
U2OS cells were infected with SINV at an moi of 1 and processed for auto-
mated microscopy or immunoblot at 8 hpi. For all of the experiments
involving siRNA, a pool of two siRNAs was used, except for the experiments
shown in Figures 6A–6C, in which one siRNA targeting each gene was used.
Immunofluorescence Microscopy
U2OS cells were transfected with the siRNAs and after 48 hr were transfected
with HA-NRAMP2. Twenty-four hours later, the cells were replated on glass
coverslips. Cells were fixed with 4% formaldehyde, permeabilized for 10 min
with 0.1% Triton X-100, and stained with the indicated antibodies. Images
were captured using a 633 objective with a Leica DMI 4000 B fluorescence
microscope, and three-dimensional deconvolution of the images was per-
formed (AutoQuantX2).
Bioinformatics and Statistical Analysis
Orthologs were determined using HomoloGene (NCBI) and the chi-square test
was used to calculate significance. Student’s t test was performed on each in-
dividual experiment. Experiments were performed at least three times and a
p value of <0.05 in each independent experiment was considered significant.
SUPPLEMENTAL INFORMATION
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